| Document and Entity Information - USD ($) | 3 Months Ended | |
| Feb. 28, 2018 | May 01, 2018 | |
| Document And Entity Information | ||
| Entity Registrant Name | iHealthcare, Inc. | |
| Entity Central Index Key | 1,634,291 | |
| Document Type | 10-Q | |
| Document Period End Date | Feb. 28, 2018 | |
| Amendment Flag | false | |
| Current Fiscal Year End Date | --11-30 | |
| Entity Well Known Seasoned Issuer | No | |
| Entity Voluntary Filers | No | |
| Entity Current Reporting Status | Yes | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Public Float | $ 21,520 | |
| Entity Common Stock Shares Outstanding | 1,086,080 | |
| Document Fiscal Period Focus | Q1 | |
| Document Fiscal Year Focus | 2,018 |
| CONSOLIDATED BALANCE SHEETS - USD ($) | Feb. 28, 2018 | Nov. 30, 2017 |
| Current Assets | ||
| Cash | $ 157 | $ 198 |
| Inventory | 285 | |
| Loan to Related Party | 2,536 | |
| Total Assets | 157 | 3,019 |
| Current Liabilities | ||
| Accrued Expenses | 7,203 | 9,465 |
| Due to related party | 43,519 | 30,743 |
| Total Current Liabilities | 50,722 | 40,208 |
| Total Liabilities | 50,722 | 40,208 |
| Stockholders' Deficit | ||
| Series A Preferred stock ($.0001 par value, 1,500,000 shares authorized; none issued and outstanding) | ||
| Series B Preferred stock ($.0001 par value, 5,000,000 shares authorized; none issued and outstanding) | ||
| Common stock ($.0001 par value 143,500,000 shares authorized and 1,086,080 outstanding as of February 28, 2018 and November 30, 2017, respectively) | 109 | 109 |
| Subscription receivable | (5,500) | |
| Additional Paid In Capital | 65,109 | 65,109 |
| Accumulated Deficit | (115,783) | (96,907) |
| Total Stockholders' Deficit | (50,565) | (37,189) |
| Total Liabilities & Stockholders' Deficit | $ 157 | $ 3,019 |
| BALANCE SHEETS (Parenthetical) - $ / shares | Feb. 28, 2018 | Nov. 30, 2017 |
| StockholdersEquity | ||
| Preferred Stock Par Or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
| Preferred Stock Shares Authorized | 6,500,000 | 6,500,000 |
| Preferred Stock Shares Issued | 0 | 0 |
| Preferred Stock Shares Outstanding | 0 | 0 |
| Common Stock Par Or Stated Value Per Share | $ .0001 | $ 0.0001 |
| Common Stock Shares Authorized | 143,500,000 | 143,500,000 |
| Common Stock Shares Issued | 1,086,080 | 1,086,080 |
| Common Stock Shares Outstanding | 1,086,080 | 1,086,080 |
| CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | |
| Feb. 28, 2018 | Feb. 28, 2017 | |
| Income Statement [Abstract] | ||
| Revenues | $ 420 | $ 545 |
| Cost of Goods Sold | 592 | 285 |
| Gross Profit (Loss) | (172) | 260 |
| Organization and Related Expenses | 7,586 | 853 |
| Professional Fees | 11,118 | 16,700 |
| Total Operating Expenses | 18,704 | 17,553 |
| Net Loss | $ (18,876) | $ (17,293) |
| Basic and Diluted net loss per share of common stock | $ (0.02) | $ (.02) |
| Weighted Average Number of Common Shares Outstanding-Basic and Diluted | 1,086,080 | 1,018,550 |
| CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 3 Months Ended | |
| Feb. 28, 2018 | Feb. 28, 2017 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Net loss | $ (18,876) | $ (17,293) |
| Write off of subscription receivable | 5,500 | |
| Write off of inventory purchases | 285 | |
| Increase in accrued expenses | 3,325 | 1,525 |
| Net cash used in operating activities | (9,766) | (15,768) |
| CASH FLOW FROM INVESTING ACTIVITIES: | ||
| Overpayment accounted for as loan to related party | (500) | (1,941) |
| Repayment from loan to related party | 3,036 | |
| Net cash provided by (used in) investing activities | 2,536 | (1,941) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Proceeds from related party loans | 9,709 | 7,643 |
| Payments made on related party loans | (2,520) | (4,901) |
| Proceeds from the sale of common shares | 19,875 | |
| Net cash provided by financing activities | 7,189 | 22,617 |
| Increase (decrease) in cash | (41) | 4,908 |
| Beginning cash balance | 198 | 33 |
| Ending cash balance | 157 | 4,941 |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION: | ||
| Interest paid | ||
| Income taxes paid | ||
| SUPPLEMENTAL DISCLOSURES OF NON-CASH INFORMATION | ||
| Expenses paid by related party on behalf of the Company | $ 5,587 | $ 1,919 |
| NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS | 3 Months Ended |
| Feb. 28, 2018 | |
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
| Organization and Description of Business | N OTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS iHealthcare Inc. (formerly Opulent Acquisition, Inc.) (the Company) was incorporated under the laws of the State of Delaware on November 25, 2014. The Company intended to serve as a vehicle to affect an asset acquisition, merger, exchange of capital stock or other business combination with a domestic or foreign business. The Company elected November 30th as its year end. On October 25, 2017, the Company entered into an agreement with John Cook for the term of thirty-six months. Under the terms of the agreement John Cook will act as a part time consultant for iHealthcare, Inc. His role shall pertain to assisting the Company with obtaining and structuring institutional financing from various commercial banks, investment banking firms, private equity firms and related financial and business issues. John Cook shall be compensated for his part time assistance as a consultant through a combination of cash and stock incentives. Compensation for Mr. Cook will occur under four phases, with the first three to occur within 365 days of the execution of the agreement, and the fourth to occur subsequently. Upon the first phase, and upon the acquisition by the Company, Mr. Cook will receive 5.0% equity in the Company. In the second phase Mr. Cook will receive 1.666% equity in the Company for the second and third acquisitions, and 1.668% equity upon acquisition of the fourth entity. In the third phase, Mr. Cook will receive 2.00% equity for each of the fifth through ninth acquisitions. If, at any point within the first 365 days, the Company’s gross revenue reaches $58,500,000 or more, then phases one, two and three shall be deemed to be vested not withstanding that nine acquisitions have occurred. Phase four shall occur if the Company’s revenue, at any point, should exceed $200,000,000 there shall be an additional 5.0% equity issued to Mr. Cook. Phase one, two and three rewards shall be Series B Preferred stock, whereas Phase four will be a new class of preferred stock. Mr. Cook shall also be paid cash compensation on all acquisitions and receive a Single Percentage Lehman of 6% for the first $1,000,000, 5% for the second, 4% for the third, 3% for the fourth and 2% thereafter for every million. In addition to all other compensation, Mr. Cook shall be paid a bonus of an additional 2% of all cash components of any acquisition which has occurred, which shall be payable three years from the execution of the agreement, or upon termination of the agreement. As of February 28, 2018, no acquisitions have occurred and no compensation has been paid pursuant to this agreement. On November 20, 2017, iHealthcare, Inc., incorporated Empower IHCC, Inc., a Florida Company, herein referred to as, “Empower IHCC.” Empower IHCC has conducted no business activity to date. iHealthcare, Inc., intends to use the entity for potential, future, unidentified acquisitions. iHealthcare, Inc., owns 50% of Empower IHCC, Inc., and Empower H.I.S., LLC, a Florida Limited Liability Company, owns the remaining 50% of the Company. Empower H.I.S., LLC is not a related party to iHealthcare, Inc., and does not share any of the same officers, or directors as iHealthcare , Inc. Per the aforementioned ASC 808 does not apply since the entity, is setup as a wholly owned subsidiary and ASC 323 would not apply since there is no consideration paid as of February 28, 2018. |
| NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
| Feb. 28, 2018 | |
| Accounting Policies [Abstract] | |
| Significant Accounting Policies | NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Principals of Consolidation These financial statements include the accounts of the Company’s wholly owned subsidiary iHealthcare, all material intercompany balances and transactions have been eliminated. Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These unaudited consolidated financial statements should be read in conjunction with the financial statements for the year ended November 30, 2017 and notes thereto. The results of operations for the three months period ended February 28, 2018 are not necessarily indicative of the results for the full fiscal year. Inventories Inventories, consisting of products available for sale, are primarily accounted for using the first-in, first-out ("FIFO") method, and are valued at the lower of cost or market value. This valuation requires iHealthcare, Inc. to make judgments, based on currently-available information, about the likely method of disposition, such as through sales to individual customers, returns to product vendors, or liquidations, and expected recoverable values of each disposition category. During the three months ended February 28, 2018, $285 of inventory was written off and expensed to cost of goods sold. Revenue Recognition The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured . The transition to AS 606 revenue recognition guidelines will not have a material effect on the Company’s revenue recognition accounting. |
| NOTE 3 - GOING CONCERN | 3 Months Ended |
| Feb. 28, 2018 | |
| Going Concern | |
| Going Concern | NOTE 3 - GOING CONCERN The Company’s unaudited interim consolidated financial statements are prepared using accounting principles generally accepted in the United States of America applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company demonstrates adverse conditions that raise substantial doubt about the Company's ability to continue as a going concern for one year following the issuance of these financial statements. These adverse conditions are negative financial trends, specifically operating loss, working capital deficiency, negative cash flow from operating activities, and other adverse key financial ratios. The Company has not established any significant source of revenue to cover its operating costs. Management plans to fund operating expenses with related party contributions to capital. There is no assurance that management's plan will be successful. The unaudited interim consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classification of liabilities that might be necessary in the event that the Company cannot continue as a going concern. |
| NOTE 4 - RELATED PARTY TRANSACTIONS | 3 Months Ended |
| Feb. 28, 2018 | |
| Related Party Transactions [Abstract] | |
| Related Party Transactions | NOTE 4 - RELATED-PARTY TRANSACTIONS Due to related party Unisource Discovery, Inc., is a related party and is controlled by our Chief Executive Officer, Noel Mijares. Unisource Discovery advanced the Company $9,709 to pay operating expenses and was repaid $750 . The total amount owed by the Company to Unisource Discovery is $8, 959 at February 28, 2018 . This is listed as due to related party in the balance sheet. The loan is unsecured, noninterest-bearing and is payable on demand. The Subpoena Company is a related party and is controlled by our CEO. During the year ended November 30, 2017 The Subpoena Company paid $3,376 in expenses on behalf of the Company. During the three months ended February 28, 2018, The Subpoena Company paid an additional $3,750 in expenses on behalf of the Company and the Company repaid The Subpoena Company $1,770. The total amount owed by the Company to The Subpoena Company is $5,356. This loan is listed as due to related party in the balance sheet and is unsecured, noninterest-bearing and is payable on demand. At November 30, 2017, the Company owed $27,367 to its CEO for payment of expenses on behalf of the Company. During the three months ended February 28, 2018, the CEO paid expenses on behalf of the Company totaling $1,837. The total amount owed by the Company to its CEO is $29,204. This loan is listed as due to related party in the balance sheet and is unsecured, noninterest-bearing and is payable on demand . Loan to related party During the three months ended February 28, 2018 the Company advanced $500 and Unisource Discovery Inc. repaid the Company $3,036 for full payment of amounts owed by the related party. Subscription Receivable As a result of the merger in 2016, a subscription receivable was contributed by the principal shareholders in the amount of $34,980. The Company has collected $21,980 from the subscription receivable and converted advances of $7,500 due to the Company’s CEO as of November 30, 2016. The balance as of November 30, 2017, $5,500, was deemed uncollectible and written off to general and administrative expenses on February 28, 2018. Office Space Our office space is located at 3901 NW 28th Street, 2nd Floor, Miami, FL 33142. This space is provided to the Company rent free by Noel Mijares, who leases the office space on his personal behalf. |
| NOTE 5 - SUBSEQUENT EVENTS | 3 Months Ended |
| Feb. 28, 2018 | |
| Subsequent Events [Abstract] | |
| Subsequent Events | NOTE 5 – SUBSEQUENT EVENTS Subsequent to February 28, 2018, a related party, The Subpoena Company, paid expenses on behalf of the Company totaling $5,548 and our CEO paid expenses on behalf of the Company totaling $1,300. On April 25, 2018 the Board of Directors approved to and subsequently issued Noel Mijares 62,500 shares of series A Preferred Stock. That same day the Board of Directors also approved to and subsequently issued David Bingaman 37,500 shares of series A Preferred Stock. |
| NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
| Feb. 28, 2018 | |
| Accounting Policies [Abstract] | |
| Principals of Consolidation | Principals of Consolidation These financial statements include the accounts of the Company’s wholly owned subsidiary iHealthcare, all material intercompany balances and transactions have been eliminated. |
| Basis of Presentation | Basis of Presentation The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These unaudited consolidated financial statements should be read in conjunction with the financial statements for the year ended November 30, 2017 and notes thereto. The results of operations for the three months period ended February 28, 2018 are not necessarily indicative of the results for the full fiscal year. |
| Inventories | Inventories Inventories, consisting of products available for sale, are primarily accounted for using the first-in, first-out ("FIFO") method, and are valued at the lower of cost or market value. This valuation requires iHealthcare, Inc. to make judgments, based on currently-available information, about the likely method of disposition, such as through sales to individual customers, returns to product vendors, or liquidations, and expected recoverable values of each disposition category. During the three months ended February 28, 2018, $285 of inventory was written off and expensed to cost of goods sold. |
| Revenue Recognition | Revenue Recognition The Company recognizes revenue when it is realized or realizable and earned. The Company considers revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists, (ii) the product has been shipped or the services have been rendered to the customer, (iii) the sales price is fixed or determinable, and (iv) collectability is reasonably assured . The transition to AS 606 revenue recognition guidelines will not have a material effect on the Company’s revenue recognition accounting. |
